Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
about
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cellsSaccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsSaccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferationAlternatives to Antibiotics to Prevent Necrotic Enteritis in Broiler Chickens: A Microbiologist's PerspectiveAn Introduction to the Avian Gut Microbiota and the Effects of Yeast-Based Prebiotic-Type Compounds as Potential Feed AdditivesSaccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a reviewModification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardiiInfluence of Saccharomyces boulardii CNCM I-745on the gut-associated immune systemInteraction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infectionBacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologistsGreen medicineCan probiotics modulate human disease by impacting intestinal barrier function?Probiotics, enteric and diarrheal diseases, and global health.Probiotics-host communication: Modulation of signaling pathways in the intestine.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceProbiotics in clostridium difficile Infection.Probiotics for the treatment of Clostridium difficile associated disease.A Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with Diarrhea.Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.Identifying molecular targets of lifestyle modifications in colon cancer prevention.The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.Models for the study of Clostridium difficile infection.Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.Striking a balance: fungal commensalism versus pathogenesisReview article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.Beneficial effects of probiotic and food borne yeasts on human healthEfficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.Antimicrobial and probiotic properties of yeasts: from fundamental to novel applicationsGleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii.A human gut ecosystem protects against C. difficile disease by targeting TcdA.
P2860
Q21198789-112E049D-7827-40D0-8FD5-976E00A89AAAQ24548845-CC2C2EDE-ED3B-46E8-B63E-436E156A2CF2Q24621081-FB48955C-4894-431A-A714-FC193E164EBAQ24654180-8F8EB712-0602-41ED-AE35-24B4997205E8Q26773141-0A0CE386-C8EE-4510-9FCD-9068D643C1DBQ26776089-0AAF8923-27FF-48FA-8F10-6BEA394DFD64Q26796416-3DAF47FB-B7BC-4560-B336-C4DE6C37E6AEQ27306197-8641F549-0CD5-4EFF-9485-F7BD9954BAC6Q28066899-C48D4B2D-83C8-4B67-BD87-9A343891DB81Q28472674-41E0DE23-103B-405B-BC4B-F7C48A0ED7FCQ28741795-5B2337AA-AA51-4154-8851-EA527FC4B4D1Q28769677-859EDBF1-1673-4F1D-B887-C6DD0D45D85BQ28817192-FFDE808C-EC90-4808-9B76-68D04E1E3EEAQ30425561-27A69161-F458-48CD-A964-D7D9DE5BA3ABQ34018028-9D7BF7E2-AC2B-4B00-A4C7-2130CFF90CB1Q34162963-4FD232B9-6D21-4E15-99D2-B42620B2772EQ34223543-E3D693B2-1209-4A1D-97E2-5037DAC75737Q34364074-2A1578A9-49DB-45EB-9D0D-D9D71EAE34B1Q34378800-E2F73CBE-C3E4-4391-9F44-BAD5512649FEQ34497819-37DDAABC-04DF-4A1B-A043-C68F1B18CAE3Q34554028-BB73713A-D767-4473-9558-C47B294CE70EQ34651881-DCF1E676-924F-4CD6-BC6A-727D99A558F5Q34832263-A858DD95-8592-4332-AD98-96D32A4F75FBQ36019356-C97D02C1-E7E6-492E-ACCC-6FFDBA1A39DDQ36823908-0D618C18-B6D3-48BB-B575-1989BD197D59Q37092848-D093C5F7-2FF4-4C60-A4D3-94DD60D6D6E5Q37586528-6B3FDD12-BE35-458C-AEAF-8748BDFBD1BEQ37976693-2C15DD24-C425-42B0-83A2-2CFE72099885Q37994188-80847A05-08A0-4813-83C0-8726FEBA8572Q38069827-144C6C2E-3202-4E3D-9329-564DF58D8A72Q38794312-DF3257DC-B044-4706-BAD1-694ADCBBEDD9Q39519683-51D090A4-2DAF-44D5-BDD6-81FEE482726BQ39723636-84BF9943-E67D-48AC-84BF-697198F8F996Q40552298-5CB91E61-46F3-4600-B4CC-679D3D77EE41Q40579622-26840690-0376-4B0D-BE67-354054421E86Q40763960-573137AD-072C-439B-ACFE-DF71ADCC0BDFQ41824565-2620F9C5-2236-4C0F-840A-42EAE97C148BQ41876318-9613EAF7-FC37-4C12-8C33-2D787BB0CDABQ42099613-0FC28CA0-F610-45A9-B031-5154CE510B3DQ42101679-B8E3CEFB-E5C7-43FF-825D-0F6DDEABA0BF
P2860
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@ast
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@en
type
label
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@ast
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@en
prefLabel
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@ast
Saccharomyces boulardii protea ...... in A effects in the rat ileum.
@en
P2093
P2860
P1476
Saccharomyces boulardii protea ...... xin A effects in the rat ileum
@en
P2093
C Pothoulakis
I Castagliuolo
J T LaMont
S T Nikulasson
P2860
P304
P407
P577
1996-12-01T00:00:00Z